These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15349826)

  • 1. The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines.
    Opdenakker G; Van Damme J
    Int J Dev Biol; 2004; 48(5-6):519-27. PubMed ID: 15349826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemokine network in cancer--much more than directing cell movement.
    Kulbe H; Levinson NR; Balkwill F; Wilson JL
    Int J Dev Biol; 2004; 48(5-6):489-96. PubMed ID: 15349823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXC chemokines in angiogenesis of cancer.
    Strieter RM; Belperio JA; Phillips RJ; Keane MP
    Semin Cancer Biol; 2004 Jun; 14(3):195-200. PubMed ID: 15246055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer.
    Strieter RM; Belperio JA; Burdick MD; Sharma S; Dubinett SM; Keane MP
    Ann N Y Acad Sci; 2004 Dec; 1028():351-60. PubMed ID: 15650260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle.
    Van Coillie E; Van Aelst I; Wuyts A; Vercauteren R; Devos R; De Wolf-Peeters C; Van Damme J; Opdenakker G
    Am J Pathol; 2001 Oct; 159(4):1405-14. PubMed ID: 11583968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.
    Fall N; Bove KE; Stringer K; Lovell DJ; Brunner HI; Weiss J; Higgins GC; Bowyer SL; Graham TB; Thornton S; Grom AA
    Arthritis Rheum; 2005 Oct; 52(10):3175-80. PubMed ID: 16200621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer CXC chemokine networks and tumour angiogenesis.
    Strieter RM; Burdick MD; Mestas J; Gomperts B; Keane MP; Belperio JA
    Eur J Cancer; 2006 Apr; 42(6):768-78. PubMed ID: 16510280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multifaceted roles of chemokines in malignancy.
    Ben-Baruch A
    Cancer Metastasis Rev; 2006 Sep; 25(3):357-71. PubMed ID: 17016763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulating the chemokine-chemokine receptor network to treat cancer.
    Ruffini PA; Morandi P; Cabioglu N; Altundag K; Cristofanilli M
    Cancer; 2007 Jun; 109(12):2392-404. PubMed ID: 17503430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in tumor-associated angiogenesis.
    Gerber PA; Hippe A; Buhren BA; Müller A; Homey B
    Biol Chem; 2009 Dec; 390(12):1213-23. PubMed ID: 19804363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does ionizing radiation stimulate cancer invasion and metastasis?
    Madani I; De Neve W; Mareel M
    Bull Cancer; 2008 Mar; 95(3):292-300. PubMed ID: 18390409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular correlates of site-specific metastasis.
    Dai CY; Haqq CM; Puzas JE
    Semin Radiat Oncol; 2006 Apr; 16(2):102-10. PubMed ID: 16564445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines: angiogenesis and metastases in lung cancer.
    Strieter RM; Belperio JA; Phillips RJ; Keane MP
    Novartis Found Symp; 2004; 256():173-84; discussion 184-8, 259-69. PubMed ID: 15027490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
    Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
    Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the immunoangiostatic CXC chemokine network.
    Balestrieri ML; Balestrieri A; Mancini FP; Napoli C
    Cardiovasc Res; 2008 May; 78(2):250-6. PubMed ID: 18252760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine-based pathogenetic mechanisms in cancer.
    Conti I; Dube C; Rollins BJ
    Novartis Found Symp; 2004; 256():29-41; discussion 41-52, 266-9. PubMed ID: 15027482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine-protease interactions in cancer.
    Van Damme J; Struyf S; Opdenakker G
    Semin Cancer Biol; 2004 Jun; 14(3):201-8. PubMed ID: 15246056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine system in cancer biology and therapy.
    Mantovani A; Savino B; Locati M; Zammataro L; Allavena P; Bonecchi R
    Cytokine Growth Factor Rev; 2010 Feb; 21(1):27-39. PubMed ID: 20004131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.